HealthExtras Announces Hiring of Chief Financial Officer
04 Abril 2008 - 7:00AM
Business Wire
HealthExtras, Inc. (NASDAQ:HLEX), a pharmacy benefit management
company, today announced that Hai Tran has been recruited to become
the Company�s Chief Financial Officer (CFO). Mr. Tran will succeed
Michael P. Donovan in the CFO position effective July 1, 2008. Mr.
Donovan has been with HealthExtras since its initial public
offering in 1999 and after a ten year career as CFO, he will be
transitioning his responsibilities to Hai Tran. Mr. Donovan will
remain with the Company and provide support on business development
opportunities. As CFO, Mr. Tran will be responsible for all of
HealthExtras� financial operations, including corporate accounting,
external reporting, financial planning, treasury, and tax. �As our
Company grows, we look to continue to develop our senior management
team,� said David T. Blair, CEO of HealthExtras. �Also, we are
grateful to Mike Donovan for his long tenure with the Company and
for his continued support role in both the CFO transition and
business development activities. Clearly Hai�s financial
experience, background in investor relations and healthcare
expertise position him to contribute to the Company�s success in
the future.� Mr. Tran was most recently Vice President and
Treasurer of Hanger Orthopedic Group, Inc. (NYSE:HGR) a $680
million publicly traded orthotic and prosthetic provider. Mr. Tran
earned a bachelor of science degree in engineering from the
University of Virginia and a masters degree in business
administration from the University of Richmond. About HealthExtras
(www.healthextras.com) HealthExtras, Inc. is a full-service
pharmacy benefit management company. Its clients include
self-insured employers, including state and local governments,
third-party administrators, managed care organizations, unions and
individuals. The Company's integrated pharmacy benefit management
services marketed under the name Catalyst Rx include: claims
processing, benefit design consultation, drug utilization review,
formulary management, drug data analysis services and mail order
services. Additionally, the Company operates a national retail
pharmacy network with over 60,000 participating pharmacies. This
press release may contain forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934.
These forward-looking statements involve a number of risks and
uncertainties. Factors that we have identified that might
materially affect our results are discussed in our Annual Report on
Form 10-K for the year ended December 31, 2007 under "Item 1.A Risk
Factors." Readers are urged to carefully review and consider the
various disclosures made in our Annual Report on Form 10-K and our
other filings with the Securities and Exchange Commission that
attempt to advise interested parties of the risks and uncertainties
that may affect our business.
Healthextras (NASDAQ:HLEX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Healthextras (NASDAQ:HLEX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Healthextras (MM) (NASDAQ): 0 recent articles
Más de HealthExtras, Inc. ArtÃculos de Noticias